Yang Liu1, Adithya S Reddy2, Joshua Cockrum3, Miranda C Ajulufoh4, Yihao Zheng5, Albert J Shih6, Aditya S Pandey7, Luis E Savastano8. 1. Department of Mechanical Engineering, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: yliume@umich.edu. 2. Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: asreddy@umich.edu. 3. Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: jcockrum@umich.edu. 4. School of Medicine, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: mcaju@med.umich.edu. 5. Mechanical Engineering, Worcester Polytechnic Institute, Worcester, Massachusetts, USA. Electronic address: yzheng8@wpi.edu. 6. Department of Mechanical Engineering, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: shiha@umich.edu. 7. Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: adityap@med.umich.edu. 8. Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan, USA; Department of Neurosurgery, Mayo Clinic, Rochester, Minnesota, USA. Electronic address: Savastano.Luis@mayo.edu.
Abstract
BACKGROUND: As access to patient emboli is limited, embolus analogs (EAs) have become critical to the research of large vessel occlusion (LVO) stroke and the development of thrombectomy technology. To date, techniques for fabricating standardized human blood-derived EAs are limited in the variety of compositions, and the mechanical properties relevant to thrombectomy are not quantified. METHODS: EAs were made by mixing human banked red blood cells (RBCs), plasma, and platelet concentrate in 10 different volumetric percentage combinations to mimic the broad range of patient emboli causing LVO strokes. The samples underwent histologic analysis and tensile testing to mimic the pulling action of thrombectomy devices, and were compared to patient emboli. RESULTS: EAs had histologic compositions of 0-96% RBCs, 0.78%-92% fibrin, and 2.1%-22% platelets, which can be correlated with the ingredients using a regression model. At fracture, EAs elongated from 81% to 136%, and the ultimate tensile stress ranged from 16 to 949 kPa. These EAs' histologic compositions and tensile properties showed great similarity to those of emboli retrieved from LVO stroke patients, indicating the validity of such EA fabrication methods. EAs with lower RBC and higher fibrin contents are more extensible and can withstand higher tensile stress. CONCLUSIONS: EAs fabricated and tested using the proposed new methods provide a platform for stroke research and pre-clinical development of thrombectomy devices.
BACKGROUND: As access to patient emboli is limited, embolus analogs (EAs) have become critical to the research of large vessel occlusion (LVO) stroke and the development of thrombectomy technology. To date, techniques for fabricating standardized human blood-derived EAs are limited in the variety of compositions, and the mechanical properties relevant to thrombectomy are not quantified. METHODS: EAs were made by mixing human banked red blood cells (RBCs), plasma, and platelet concentrate in 10 different volumetric percentage combinations to mimic the broad range of patient emboli causing LVO strokes. The samples underwent histologic analysis and tensile testing to mimic the pulling action of thrombectomy devices, and were compared to patient emboli. RESULTS: EAs had histologic compositions of 0-96% RBCs, 0.78%-92% fibrin, and 2.1%-22% platelets, which can be correlated with the ingredients using a regression model. At fracture, EAs elongated from 81% to 136%, and the ultimate tensile stress ranged from 16 to 949 kPa. These EAs' histologic compositions and tensile properties showed great similarity to those of emboli retrieved from LVO stroke patients, indicating the validity of such EA fabrication methods. EAs with lower RBC and higher fibrin contents are more extensible and can withstand higher tensile stress. CONCLUSIONS: EAs fabricated and tested using the proposed new methods provide a platform for stroke research and pre-clinical development of thrombectomy devices.
Authors: Jean-Philippe Collet; Henry Shuman; Robert E Ledger; Seungtaek Lee; John W Weisel Journal: Proc Natl Acad Sci U S A Date: 2005-06-20 Impact factor: 11.205
Authors: T Boeckh-Behrens; M Schubert; A Förschler; S Prothmann; K Kreiser; C Zimmer; J Riegger; J Bauer; F Neff; V Kehl; J Pelisek; L Schirmer; M Mehr; H Poppert Journal: Clin Neuroradiol Date: 2014-09-27 Impact factor: 3.649
Authors: Gillian M Gunning; Kevin McArdle; Mahmood Mirza; Sharon Duffy; Michael Gilvarry; Patrick A Brouwer Journal: J Neurointerv Surg Date: 2017-01-02 Impact factor: 5.836
Authors: Yang Liu; Yihao Zheng; Adithya S Reddy; Daniel Gebrezgiabhier; Evan Davis; Joshua Cockrum; Joseph J Gemmete; Neeraj Chaudhary; Julius M Griauzde; Aditya S Pandey; Albert J Shih; Luis E Savastano Journal: J Neurosurg Date: 2020-02-28 Impact factor: 5.115
Authors: Osama O Zaidat; Alicia C Castonguay; Italo Linfante; Rishi Gupta; Coleman O Martin; William E Holloway; Nils Mueller-Kronast; Joey D English; Guilherme Dabus; Tim W Malisch; Franklin A Marden; Hormozd Bozorgchami; Andrew Xavier; Ansaar T Rai; Michael T Froehler; Aamir Badruddin; Thanh N Nguyen; M Asif Taqi; Michael G Abraham; Albert J Yoo; Vallabh Janardhan; Hashem Shaltoni; Roberta Novakovic; Alex Abou-Chebl; Peng R Chen; Gavin W Britz; Chung-Huan J Sun; Vibhav Bansal; Ritesh Kaushal; Ashish Nanda; Raul G Nogueira Journal: Stroke Date: 2018-02-19 Impact factor: 7.914
Authors: Joris M Niesten; Irene C van der Schaaf; Lievay van Dam; Aryan Vink; Jan Albert Vos; Wouter J Schonewille; Peter C de Bruin; Willem P T M Mali; Birgitta K Velthuis Journal: PLoS One Date: 2014-02-11 Impact factor: 3.240
Authors: S T Fitzgerald; Y Liu; D Dai; O M Mereuta; M Abbasi; J L A Larco; A S Douglas; D F Kallmes; L Savastano; K M Doyle; W Brinjikji Journal: AJNR Am J Neuroradiol Date: 2021-04-08 Impact factor: 4.966
Authors: Yang Liu; Mehdi Abbasi; Jorge L Arturo Larco; Ramanathan Kadirvel; David F Kallmes; Waleed Brinjikji; Luis Savastano Journal: J Neurointerv Surg Date: 2021-03-15 Impact factor: 8.572